Currax Announces Outstanding 2024 Financial and Operational Performance
For a second year in a row, Currax delivered greater than 50% year-over-year revenue growth for CONTRAVE®/MYSIMBA® in 2024.
Association of Optometrists2m
Glaucoma UK launches research grants programme
A total of £370,000 is set to be awarded as grants for research projects in the charity’s largest-ever funding round ...